Cargando…

Onset of pulmonary Epstein–Barr virus‐positive diffuse large B‐cell lymphoma in a patient with silicosis

How Epstein–Barr virus (EBV)‐positive diffuse large B‐cell lymphoma (DLBCL) occasionally occurs following chronic inflammation remains to be elucidated. The case of a 57‐year‐old man who developed pulmonary EBV‐positive DLBCL from underlying silicosis lesions is presented. Immunohistochemical examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogata, Ryosuke, Soda, Hiroshi, Tanaka, Yasuhiro, Senju, Hiroaki, Shimada, Midori, Yamashita, Koki, Nakashima, Shota, Umemura, Asuka, Yoshida, Masataka, Hara, Takuya, Jinnai, Saeko, Iwasaki, Keisuke, Fukuda, Yuichi, Yamaguchi, Hiroyuki, Mukae, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720632/ https://www.ncbi.nlm.nih.gov/pubmed/34821472 http://dx.doi.org/10.1111/1759-7714.14250

Ejemplares similares

Hypertrophic osteoarthropathy associated with lung cancer: Possible links among hypoxia‐inducible factor‐1α, vascular endothelial growth factor, and hypervascularization
por: Tagawa, Ryuta, et al.
Publicado: (2023)

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases
por: Ogata, Ryosuke, et al.
Publicado: (2022)

Presence of few PD‐1‐expressing tumor‐infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non‐small cell lung cancer: An exploratory case series
por: Ogawara, Daiki, et al.
Publicado: (2018)

Vildagliptin‐induced ground‐glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementation
por: Tanaka, Yasuhiro, et al.
Publicado: (2020)

Successful treatment with nivolumab for lung cancer with low expression of PD‐L1 and prominent tumor‐infiltrating B cells and immunoglobulin G
por: Suyama, Takayuki, et al.
Publicado: (2018)

Exploring the ethical complexities of do‐not‐attempt‐resuscitation orders using the approach of advance care planning
por: Ogata, Ryo, et al.
Publicado: (2023)

Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
por: Takemoto, Shinnosuke, et al.
Publicado: (2017)

Intrathoracic amyloid tumors that presented as yellowish multinodular endobronchial protrusions with irregular vascularity and easy bleeding
por: Tomono, Hiromi, et al.
Publicado: (2019)

Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generating study
por: Soda, Hiroshi, et al.
Publicado: (2018)

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
por: Ikeda, Takaya, et al.
Publicado: (2020)

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
por: Dotsu, Yosuke, et al.
Publicado: (2021)

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study
por: Tomono, Hiromi, et al.
Publicado: (2023)

Special Issue: Epstein–Barr–Virus–Associated Cancers
por: Nanbo, Asuka
Publicado: (2021)

Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab
por: Okamura, Kazuaki, et al.
Publicado: (2017)

Pitfalls in diagnosis with the use of circulating tumor‐derived epidermal growth factor receptor mutations in lung cancer harboring pretreatment T790M
por: Ogawara, Daiki, et al.
Publicado: (2017)

Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets
por: Shimada, Midori, et al.
Publicado: (2023)

Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017)

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy
por: Ogawara, Daiki, et al.
Publicado: (2017)

Epstein-Barr Virus Exploits the Secretory Pathway to Release Virions
por: Nanbo, Asuka
Publicado: (2020)

Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial　tissues of rheumatoid arthritis
por: Masuoka, Shotaro, et al.
Publicado: (2018)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2019)

How Does Epstein–Barr Virus Contribute to Chronic Periodontitis?
por: Imai, Kenichi, et al.
Publicado: (2020)

Extracellular Vesicles in Epstein-Barr Virus’ Life Cycle and Pathogenesis
por: Zhao, Mengmeng, et al.
Publicado: (2019)

Pathogenic Role of Epstein–Barr Virus in Lung Cancers
por: Becnel, David, et al.
Publicado: (2021)

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release
por: Uddin, Md Kamal, et al.
Publicado: (2023)

Replication of Epstein-Barr Virus Primary Infection in Human Tonsil Tissue Explants
por: Gotoh, Kensei, et al.
Publicado: (2011)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Epstein-Barr Virus Dacryoadenitis in a Young Woman
por: Watanabe, Tamami, et al.
Publicado: (2022)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Elderly‐onset systemic Epstein–Barr virus‐positive T‐cell lymphoma of childhood
por: Nishikubo, Masashi, et al.
Publicado: (2022)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
por: Ban, Yumiko, et al.
Publicado: (2020)

Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring
por: Gyotoku, Hiroshi, et al.
Publicado: (2020)

Primary pleural lymphoma accompanied by silicosis
por: Matano, Yoshiki, et al.
Publicado: (2023)

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity
por: Masud, H. M. Abdullah Al, et al.
Publicado: (2019)

Epstein–Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers
por: Nanbo, Asuka, et al.
Publicado: (2018)

Silicosis
por: Henderson, Fergus L.
Publicado: (1929)

Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults
por: Wang, Ziyao, et al.
Publicado: (2021)

EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS
por: KIMURA, HIROSHI, et al.
Publicado: (2013)

Cancer stem cells in Epstein‐Barr virus‐associated gastric carcinoma
por: Yasui, Mariko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3cg4ap1ch9ed68bpclfrthsl6